A major breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant protector protein is frequently disabled in various kinds of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research